Azimuth Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$7.35M Buy
198,681
+157,990
+388% +$6.16M 0.31% 122
2021
Q4
$1.85M Sell
40,691
-78,643
-66% -$4.1M 0.07% 201
2021
Q3
$7.56M Sell
119,334
-2,006
-2% -$153K 0.32% 117
2021
Q2
$11.1M Buy
121,340
+6,343
+6% +$504K 0.48% 78
2021
Q1
$7.83M Buy
+114,997
New +$8.93M 0.37% 101

Other funds holding CDNA

Azimuth Capital Management's CDNA Position: Q1 2022 in Review

Azimuth Capital Management increased its CareDx (CDNA) stake by 388% in Q1 2022, buying an estimated $6.16M and bringing the position to 198,681 shares worth $7.35M. The position accounts for 0.31% of the portfolio, ranked #122.

Azimuth Capital Management first reported a position in CDNA in Q1 2021 and has held it in 5 quarters since. The position peaked at $11.1M in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Azimuth Capital Management held 198,681 shares of CareDx worth $7.35M as of Q1 2022.
  • Azimuth Capital Management bought 157,990 CareDx shares in Q1 2022, an estimated $6.16M.
  • CareDx made up 0.31% of Azimuth Capital Management's portfolio in Q1 2022, its #122 holding.
  • Azimuth Capital Management first reported a position in CareDx in Q1 2021 and has held it in 5 quarters since.
  • Azimuth Capital Management's CareDx position peaked at $11.1M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.